BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 7604767)

  • 1. Treatment of psoriasis: role of calcipotriene.
    Kirsner RS; Federman D
    Am Fam Physician; 1995 Jul; 52(1):237-40, 243-4. PubMed ID: 7604767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcipotriene/betamethasone in the treatment of psoriasis: a review article.
    Saraceno R; Gramiccia T; Frascione P; Chimenti S
    Expert Opin Pharmacother; 2009 Oct; 10(14):2357-65. PubMed ID: 19663634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical application of calcipotriene and corticosteroids: combination regimens.
    Lebwohl M
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S55-8. PubMed ID: 9344186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical psoriasis therapy.
    Federman DG; Froelich CW; Kirsner RS
    Am Fam Physician; 1999 Feb; 59(4):957-62, 964. PubMed ID: 10068717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic plaque psoriasis.
    Luba KM; Stulberg DL
    Am Fam Physician; 2006 Feb; 73(4):636-44. PubMed ID: 16506705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of topical vitamin D modulators in psoriasis therapy.
    Tanghetti EA
    J Drugs Dermatol; 2009 Aug; 8(8 Suppl):s4-8. PubMed ID: 19702030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of topical calcipotriene/calcipotriol in conditions other than plaque-type psoriasis.
    Thiers BH
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S69-71. PubMed ID: 9344189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Comparative Study to Evaluate Epidermal Barrier Integrity of Psoriasis Patients Treated With Calcipotriene/Betamethasone Topical Suspension Versus Betamethasone Dipropionate 0.05% Lotion.
    Hashim PW; Nia JK; Terrano D; Goldenberg G; Kircik LH
    J Drugs Dermatol; 2017 Aug; 16(8):747-752. PubMed ID: 28809989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined topical calcipotriene ointment 0.005% and various systemic therapies in the treatment of plaque-type psoriasis vulgaris: review of the literature and results of a survey sent to 100 dermatologists.
    Katz HI
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S62-8. PubMed ID: 9344188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photosensitivity associated with combined UV-B and calcipotriene therapy.
    McKenna KE; Stern RS
    Arch Dermatol; 1995 Nov; 131(11):1305-7. PubMed ID: 7503575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psoriasis in infancy: therapy with calcipotriene ointment.
    Travis LB; Silverberg NB
    Cutis; 2001 Nov; 68(5):341-4. PubMed ID: 11766119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of vitamin D analog use for the treatment of psoriasis.
    Ahn CS; Awadalla F; Huang KE; Yentzer B; Dabade TS; Feldman SR
    J Drugs Dermatol; 2013 Aug; 12(8):906-10. PubMed ID: 23986164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of psoriasis with calcipotriol used as monotherapy.
    Ramsay CA
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S53-4. PubMed ID: 9344185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New developments in topical sequential therapy for psoriasis.
    Koo JY
    Skin Therapy Lett; 2005 Nov; 10(9):1-4. PubMed ID: 16292458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcitriol 3 microg/g ointment: an effective and safe addition to the armamentarium in topical psoriasis therapy.
    Abramovits W
    J Drugs Dermatol; 2009 Aug; 8(8 Suppl):s17-22. PubMed ID: 19702032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis.
    Menter A; Abramovits W; Colón LE; Johnson LA; Gottschalk RW
    J Drugs Dermatol; 2009 Jan; 8(1):52-7. PubMed ID: 19180896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis.
    Austad J; Bjerke JR; Gjertsen BT; Helland S; Livden JK; Morken T; Mørk NJ
    J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):19-24. PubMed ID: 9731961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the potential clinical benefits of switching patients with plaque psoriasis from calcipotriene to tazarotene treatment.
    Coynik D
    Cutis; 2000 Dec; 66(6 Suppl):19-24. PubMed ID: 11147087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D3 analogues.
    Kragballe K
    Dermatol Clin; 1995 Oct; 13(4):835-9. PubMed ID: 8785887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of intertriginous psoriasis: from the Medical Board of the National Psoriasis Foundation.
    Kalb RE; Bagel J; Korman NJ; Lebwohl MG; Young M; Horn EJ; Van Voorhees AS;
    J Am Acad Dermatol; 2009 Jan; 60(1):120-4. PubMed ID: 19103363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.